公开(公告)号：EP2258719A1

公开(公告)日：2010-12-08

申请号：EP09160679.8

申请日：2009-05-19

申请人： Max-Delbrück-Centrum für Molekulare Medizin (MDC)

发明人： Blankenstein, Thomas, Prof. Dr. ,  Charo, Jehad, Dr. ,  Uckert, Wolfgang, Prof. Dr. ,  Kieback, Elisa ,  Perez, Cynthia

IPC分类号： C07K14/705 ,  C12N15/62 ,  A61K38/17 ,  A61P35/00

CPC分类号： C07K14/7051 ,  A61K38/00 ,  C07K2319/33

摘要： The present invention is directed to a functional T cell receptor (TCR) fusion protein (TFP) recognizing and binding to at least one MHC-presented epitope, and containing at least one amino acid sequence recognizing and binding an antigen. The present invention is further directed to an isolated nucleic acid molecule encoding the same, a T cell expressing said TFP, and a pharmaceutical composition for use in the treatment of diseases involving malignant cells expressing said tumor-associated antigen.

摘要翻译： 本发明涉及识别并结合至少一种MHC-呈递的表位并含有至少一个识别和结合抗原的氨基酸序列的功能性T细胞受体（TCR）融合蛋白（TFP）。 本发明还涉及编码它的分离的核酸分子，表达所述TFP的T细胞和用于治疗涉及表达所述肿瘤相关抗原的恶性细胞的疾病的药物组合物。